NCT00040092
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
Not specified
Clinical trial condition
Endocrine Gland Neoplasms
Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.
6,077 public trials
1,365 recruiting studies
Endocrine Gland Neoplasms trial results
Completed
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
NCT00157560
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy
NCT00121030
- Conditions
- Adnexal Diseases, Anemia, Endocrine Gland Neoplasms, +18 more
- Locations
-
Not specified
NCT00576940
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
- Locations
-
- 1st Deparment of General Surgery Krakow, Krkaow, Poland
NCT00439478
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +10 more
- Locations
-
- University Hospital Basel, Switzerland
NCT00558155
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +15 more
- Locations
-
- 1st Department of General Surgery Krakow, Poland
NCT00436423
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- YeulHong Kim Seoul, South Korea
Completed
Pyrosequencing of the BRAFV600E Mutation
NCT00551486
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +4 more
- Locations
-
- Chungnam National University Hospital Daejeon, South Korea
NCT00191568
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Grenoble, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Lyon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Marseille, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Montpellier, France
NCT00462475
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +32 more
- Locations
-
- Department of Molecular and Clinical Endocirnology and Oncology University Federico II of Naples Naples, Italy